ABS Inc. (Vancouver, BC Canada), now partnered with Parallel Biotechnologies LLP (Miami Beach, Florida) holds patents regarding use of non-invasive low frequency vibration massage (i.e. 1 - 1000 Hz, not ultrasound!) to accelerate IV thrombolytic drug action in emergency treatment of heart attack and stroke. US Patent No. 7517328 claims localized vibration massage to assist thrombolytic drug action in heart attack acute ischemic stroke (i.e. in both cases a drug delivery system). US Patent No. 8870796 more particularly claims use of a vibrator for deploying carotid arterial vibration for acute stroke victims (see video below). Noninvasive vibration penetrates to a culprit vessel to help disrupt thrombosis, cause vasodilation, and enhance mixing of systemically delivered drugs into a thrombosed artery. ABS has consulted world class experts, and conducted some bench-top research and clinical feasibility studies in advancement of the technology. ABS and Parallel are aggressively seeking partnership to advance the technology from bench top, through prototype, clinical trials and market approval. An Angel passionate to revolutionize cardiovascular emergency care is sought.